Fresenius SE EPS - Earnings per Share 2016-2024 | FSNUY

Fresenius SE annual and quarterly earnings per share history from 2016 to 2024. Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
  • Fresenius SE EPS for the quarter ending June 30, 2024 was $-0.18, a 556.41% decline year-over-year.
  • Fresenius SE EPS for the twelve months ending June 30, 2024 was $-0.53, a 216.16% decline year-over-year.
  • Fresenius SE 2023 annual EPS was $-0.28, a 144.17% decline from 2022.
  • Fresenius SE 2022 annual EPS was $0.64, a 33.3% decline from 2021.
  • Fresenius SE 2021 annual EPS was $0.96, a 10.3% increase from 2020.
Fresenius SE Annual EPS
2023 $-0.28
2022 $0.64
2021 $0.96
2020 $0.87
2019 $0.95
2018 $1.07
2017 $0.92
2016 $0.80
2015 $0.69
Fresenius SE Quarterly EPS
2024-06-30 $-0.18
2024-03-31 $0.13
2023-12-31 $-0.29
2023-09-30 $-0.20
2023-06-30 $0.04
2023-03-31 $0.16
2022-12-31 $0.11
2022-09-30 $0.14
2022-06-30 $0.18
2022-03-31 $0.21
2021-12-31 $0.26
2021-09-30 $0.22
2021-06-30 $0.25
2021-03-31 $0.24
2020-12-31 $0.22
2020-09-30 $0.23
2020-06-30 $0.20
2020-03-31 $0.23
2019-12-31 $0.26
2019-09-30 $0.22
2019-06-30 $0.24
2019-03-31 $0.23
2018-12-31 $0.26
2018-09-30 $0.22
2018-06-30 $0.35
2018-03-31 $0.24
2017-12-31 $0.27
2017-09-30 $0.21
2017-06-30 $0.22
2017-03-31 $0.22
2016-12-31 $0.22
2016-09-30 $0.20
2016-06-30 $0.20
2016-03-31 $0.18
2015-12-31 $0.18
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $20.921B $24.011B
Fresenius SE & Co is a health care company. It offers products and services for dialysis, hospitals and outpatient treatment. The company's business segment consists of Fresenius Medical Care is engaged in treating with chronic kidney failure; Fresenius Helios is a hospital operator; Fresenius Kabi supplies essential drugs, clinical nutrition products, medical devices and services and Fresenius Vamed plans, develops and manages healthcare facilities. Fresenius SE & Co is headquartered in Bad Homburg, Germany.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $17.320B 17.55
DaVita (DVA) United States $12.060B 15.60
Encompass Health (EHC) United States $10.267B 24.21
Chemed (CHE) United States $8.277B 25.44
Elanco Animal Health (ELAN) United States $6.357B 14.29
RadNet (RDNT) United States $5.166B 122.54
Option Care Health (OPCH) United States $3.999B 18.95
Amedisys (AMED) United States $3.199B 22.78
Astrana Health (ASTH) United States $2.920B 41.31
LifeStance Health (LFST) United States $2.728B 0.00
Addus HomeCare (ADUS) United States $2.375B 27.86
U.S Physical Therapy (USPH) United States $1.464B 38.53
Pennant (PNTG) United States $1.004B 46.00
Aveanna Healthcare Holdings (AVAH) United States $0.929B 0.00
Atai Life Sciences (ATAI) Germany $0.198B 0.00
Daxor (DXR) United States $0.047B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.015B 0.00
Psychemedics (PMD) United States $0.014B 0.00
ATI Physical Therapy (ATIP) United States $0.013B 0.00
Ontrak (OTRK) United States $0.007B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00